STOCKWATCH
·
Medical Specialities
Quarterly ResultMay 10, 2026, 04:08 PM

RadNet Q1 Revenue +22.1% to $575.6M; Raises Full-Year Guidance

AI Summary

RadNet reported strong first-quarter 2026 financial results, with total company revenue increasing 22.1% to $575.6 million and Adjusted EBITDA rising 36.3% to $63.3 million. The Digital Health segment saw revenue grow 51.5% to $29.1 million, driven by strategic investments and the acquisition of Gleamer SAS. The company also announced a new joint venture with Trinity Health and raised its full-year 2026 Imaging Center guidance for revenue, Adjusted EBITDA, and Free Cash Flow.

Key Highlights

  • Total Company Revenue increased 22.1% to $575.6 million in Q1 2026.
  • Total Company Adjusted EBITDA increased 36.3% to $63.3 million in Q1 2026.
  • Digital Health segment revenue grew 51.5% to $29.1 million in Q1 2026.
  • Digital Health Annual Recurring Revenue (ARR) reached $96.9 million at March 31, 2026.
  • Adjusted Diluted Loss Per Share was $(0.28) in Q1 2026, an improvement from $(0.34) in Q1 2025.
  • Revised full-year 2026 Imaging Center Revenue guidance to $2,355 - $2,405 million.
  • Revised full-year 2026 Imaging Center Adjusted EBITDA guidance to $340 - $353 million.
  • Commenced a new health system joint venture with Trinity Health's Saint Alphonsus Health System.
RDNT
Medical Specialities
RadNet, Inc.

Price Impact